TDP-43—The key to understanding amyotrophic lateral sclerosis

References

• Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 2013; 14:248-64; PMID:23463272; http://dx.doi.org/10.1038/nrn3430
   PubMed Web of Science ®Google Scholar
• Johnson JO, Pioro EP, Boehringer A, Chia R, Feit H, Renton AE, Pliner HA, Abramzon Y, Marangi G, Winborn BJ, et al. Mutations in the matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci 2014; 17:664-6; PMID:24686783; http://dx.doi.org/10.1038/nn.3688
   PubMed Web of Science ®Google Scholar
• Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 2011; 7:616-30; PMID:22051914; http://dx.doi.org/10.1038/nrneurol.2011.152
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 2010; 9:995-1007.
   Google Scholar
• Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 2013; 79:416-38; PMID:23931993; http://dx.doi.org/10.1016/j.neuron.2013.07.033
   PubMed Web of Science ®Google Scholar
• Buratti E, Baralle FE. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol 2010; 7:420-9; PMID:20639693; http://dx.doi.org/10.4161/rna.7.4.12205
   PubMed Web of Science ®Google Scholar
• Freibaum BD, Chitta RK, High AA, Taylor JP. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res 2010; 9:1104-20; PMID:20020773; http://dx.doi.org/10.1021/pr901076y
   PubMed Web of Science ®Google Scholar
• Ling SC, Albuquerque CP, Han JS, Lagier-Tourenne C, Tokunaga S, Zhou H, Cleveland DW. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci U S A 2010; 107:13318-23; PMID: 20624952; http://dx.doi.org/10.1073/pnas.1008227107
   PubMed Web of Science ®Google Scholar
• Sephton CF, Cenik C, Kucukural A, Dammer EB, Cenik B, Han Y, Dewey CM, Roth FP, Herz J, Peng J, et al. Identification of Neuronal RNA Targets of TDP-43-containing ribonucleoprotein complexes. J Biol Chem 2010; 286:1204-15; PMID:21051541; http://dx.doi.org/10.1074/jbc.M110.190884
   PubMed Web of Science ®Google Scholar
• Kim SH, Shanware NP, Bowler MJ, Tibbetts RS. Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to Co-regulate HDAC6 mRNA. J Biol Chem 2010; 285:34097-105; PMID:20720006; http://dx.doi.org/10.1074/jbc.M110.154831
   PubMed Web of Science ®Google Scholar
• Buratti E, De Conti L, Stuani C, Romano M, Baralle M, Baralle F. Nuclear factor TDP-43 can affect selected microRNA levels. Febs J 2010; 277:2268-81; PMID:20423455; http://dx.doi.org/10.1111/j.1742-4658.2010.07643.x
   PubMed Web of Science ®Google Scholar
• Kawahara Y, Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad of Sci 2012; 109:3347-52.
   Google Scholar
• Abhyankar MM, Urekar C, Reddi PP. A novel CpG-free vertebrate insulator silences the testis-specific SP-10 gene in somatic tissues: role for TDP-43 in insulator function. J Biol Chem 2007; 282:36143-54; PMID:17932037; http://dx.doi.org/10.1074/jbc.M705811200
   PubMed Web of Science ®Google Scholar
• Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 2010; 30:639-49; PMID:20071528; http://dx.doi.org/10.1523/JNEUROSCI.4988-09.2010
   PubMed Web of Science ®Google Scholar
• Sephton CF, Good SK, Atkin S, Dewey CM, Mayer P, Herz J, Yu G. TDP-43 is a developmentally-regulated protein essential for early embryonic development. J Biol Chem 2009; 285:6826-34; PMID: 20040602; http://dx.doi.org/10.1074/jbc.M109.061846
   PubMed Web of Science ®Google Scholar
• Kraemer BC, Schuck T, Wheeler JM, Robinson LC, Trojanowski JQ, Lee VM, Schellenberg GD. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol 2010; 119:409-19; PMID:20198480; http://dx.doi.org/10.1007/s00401-010-0659-0
   PubMed Web of Science ®Google Scholar
• Chiang P-M, Ling J, Jeong YH, Price DL, Aja SM, Wong PC. Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc Nat Acad Sci 2010; 107:16320-24.
   PubMed Web of Science ®Google Scholar
• Liachko NF, Guthrie CR, Kraemer BC. Phosphorylation promotes neurotoxicity in a caenorhabditis elegans model of TDP-43 proteinopathy. J Neurosci 2010; 30:16208-19; PMID:21123567; http://dx.doi.org/10.1523/JNEUROSCI.2911-10.2010
   PubMed Web of Science ®Google Scholar
• Estes PS, Boehringer A, Zwick R, Tang JE, Grigsby B, Zarnescu DC. Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum Mol Genet 2011; 20:2308-21; PMID:21441568; http://dx.doi.org/10.1093/hmg/ddr124
   PubMed Web of Science ®Google Scholar
• Kabashi E, Lin L, Tradewell ML, Dion PA, Bercier V, Bourgouin P, Rochefort D, Bel Hadj S, Durham HD, Vande Velde C, et al. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet 2010; 19:671-83; PMID:19959528; http://dx.doi.org/10.1093/hmg/ddp534
   PubMed Web of Science ®Google Scholar
• Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351:602-11; PMID:17084815; http://dx.doi.org/10.1016/j.bbrc.2006.10.093
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314:130-3; PMID: 17023659; http://dx.doi.org/10.1126/science.1134108
   PubMed Web of Science ®Google Scholar
• Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Velde CV, Bouchard J-P, Lacomblez L, Pochigaeva K, Salachas F, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008; 40:572-4; PMID:18372902; http://dx.doi.org/10.1038/ng.132
   PubMed Web of Science ®Google Scholar
• Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Science 2008; 319:1668-72; PMID:18309045; http://dx.doi.org/10.1126/science.1154584
   PubMed Web of Science ®Google Scholar
• Smith DH, Johnson VE, Stewart W. Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nat Rev Neurol 2013; 9:211-21; PMID: 23458973; http://dx.doi.org/10.1038/nrneurol.2013.29
   PubMed Web of Science ®Google Scholar
• Halliday G, Bigio E, Cairns N, Neumann M, Mackenzie IA, Mann DA. Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects. Acta Neuropathol 2012; 124:373-82; PMID:22878865; http://dx.doi.org/10.1007/s00401-012-1030-4
   PubMed Web of Science ®Google Scholar
• Da Cruz S, Cleveland DW. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr Opin Neurobiol 2011; 21:904-19; PMID:21813273; http://dx.doi.org/10.1016/j.conb.2011.05.029
   PubMed Web of Science ®Google Scholar
• Tsao W, Jeong YH, Lin S, Ling J, Price DL, Chiang P-M, Wong PC. Rodent models of TDP-43: Recent advances. Brain Research 2012; 1462:26-39; PMID: 22608070; http://dx.doi.org/10.1016/j.brainres.2012.04.031
   PubMed Web of Science ®Google Scholar
• Stallings NR, Puttaparthi K, Luther CM, Burns DK, Elliott JL. Progressive motor weakness in transgenic mice expressing human TDP-43. Neurobiol Dis 2010; 40:404-14; PMID:20621187; http://dx.doi.org/10.1016/j.nbd.2010.06.017
   PubMed Web of Science ®Google Scholar
• Tsai KJ, Yang CH, Fang YH, Cho KH, Chien WL, Wang WT, Wu TW, Lin CP, Fu WM, Shen CK. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J Exp Med 2010; 207:1661-73; PMID:20660618; http://dx.doi.org/10.1084/jem.20092164
   PubMed Web of Science ®Google Scholar
• Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I, Smits V, Ceuterick-de Groote C, Van Broeckhoven C, Kumar-Singh S. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Nat Acad Sci 2010; 107:3858-63.
   Google Scholar
• Xu YF, Gendron TF, Zhang YJ, Lin WL, D'Alton S, Sheng H, Casey MC, Tong J, Knight J, Yu X, et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci 2010; 30:10851-9; PMID:20702714; http://dx.doi.org/10.1523/JNEUROSCI.1630-10.2010
   PubMed Web of Science ®Google Scholar
• Igaz LM, Kwong LK, Lee EB, Chen-Plotkin A, Swanson E, Unger T, Malunda J, Xu Y, Winton MJ, Trojanowski JQ, et al. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Invest 2011; 121:726-38; PMID:21206091; http://dx.doi.org/10.1172/JCI44867
   PubMed Web of Science ®Google Scholar
• Swarup V, Phaneuf D, Dupre N, Petri S, Strong M, Kriz J, Julien JP. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways. J Exp Med 2011; 208:2429-47; PMID:22084410; http://dx.doi.org/10.1084/jem.20111313
   PubMed Web of Science ®Google Scholar
• Gitcho M, Bigio E, Mishra M, Johnson N, Weintraub S, Mesulam M, Rademakers R, Chakraverty S, Cruchaga C, Morris J, et al. TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy. Acta Neuropathologica 2009; 118:633-45; PMID:19618195; http://dx.doi.org/10.1007/s00401-009-0571-7
   PubMed Web of Science ®Google Scholar
• Watanabe S, Kaneko K, Yamanaka K. Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins. J Biol Chem 2013; 288:3641-54; PMID:23235148; http://dx.doi.org/10.1074/jbc.M112.433615
   PubMed Web of Science ®Google Scholar
• Austin JA, Wright GS, Watanabe S, Grossmann JG, Antonyuk SV, Yamanaka K, Hasnain SS. Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life. Proc Natl Acad Sci U S A 2014; 111:4309-14; PMID:24591609; http://dx.doi.org/10.1073/pnas.1317317111
   PubMed Web of Science ®Google Scholar
• Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, Phatnani HP, Puddifoot CA, Story D, Fletcher J, et al. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci U S A 2012; 109:5803-8; PMID:22451909; http://dx.doi.org/10.1073/pnas.1202922109
   PubMed Web of Science ®Google Scholar
• Serio A, Bilican B, Barmada SJ, Ando DM, Zhao C, Siller R, Burr K, Haghi G, Story D, Nishimura AL, et al. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc Natl Acad Sci U S A 2013; 110:4697-702; PMID:23401527; http://dx.doi.org/10.1073/pnas.1300398110
   PubMed Web of Science ®Google Scholar
• Ayala YM, De Conti L, Avendano-Vazquez SE, Dhir A, Romano M, D'Ambrogio A, Tollervey J, Ule J, Baralle M, Buratti E, et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 2011; 30:277-88; PMID:21131904; http://dx.doi.org/10.1038/emboj.2010.310
   PubMed Web of Science ®Google Scholar
• Avendano-Vazquez SE, Dhir A, Bembich S, Buratti E, Proudfoot N, Baralle FE. Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev 2012; 26:1679-84; PMID:22855830; http://dx.doi.org/10.1101/gad.194829.112
   PubMed Web of Science ®Google Scholar
• Kim SH, Shanware NP, Bowler MJ, Tibbetts RS. Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. J Biol Chem 2010; 285:34097-105; PMID:20720006; http://dx.doi.org/10.1074/jbc.M110.154831
   PubMed Web of Science ®Google Scholar
• Xu Z. Does a loss of TDP-43 function cause neurodegeneration? Mol Neurodegener 2012; 7:27; PMID:22697423
   PubMed Web of Science ®Google Scholar
• Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem 2009; 284:20329-39; PMID:19465477; http://dx.doi.org/10.1074/jbc.M109.010264
   PubMed Web of Science ®Google Scholar
• Yang C, Tan W, Whittle C, Qiu L, Cao L, Akbarian S, Xu Z. The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism. PLoS One 2010; 5:e15878.
   PubMed Web of Science ®Google Scholar
• King OD, Gitler AD, Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res 2012; 1462:61-80.; PMID:22445064; http://dx.doi.org/10.1016/j.brainres.2012.01.016
   PubMed Web of Science ®Google Scholar
• Kanouchi T, Ohkubo T, Yokota T. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation? J Neurol Neurosurg Psychiat 2012; 83:739-45; PMID:22544947; http://dx.doi.org/10.1136/jnnp-2011-301826
   PubMed Web of Science ®Google Scholar
• Ravits J, Appel S, Baloh RH, Barohn R, Brooks BR, Elman L, Floeter MK, Henderson C, Lomen-Hoerth C, Macklis JD, et al. Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotroph Lateral Scler Frontotemporal Degener 2013; 14(Suppl 1):5-18; http://dx.doi.org/10.3109/21678421.2013.778548
   PubMed Web of Science ®Google Scholar
• Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T, Yoshida M, Murayama S, Mann DM, Akiyama H, et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep 2013; 4:124-34; PMID:23831027; http://dx.doi.org/10.1016/j.celrep.2013.06.007
   PubMed Web of Science ®Google Scholar
• Vanden Broeck L, Naval-Sanchez M, Adachi Y, Diaper D, Dourlen P, Chapuis J, Kleinberger G, Gistelinck M, Van Broeckhoven C, Lambert J-C, et al. TDP-43 loss-of-function causes neuronal loss due to defective steroid receptor-mediated gene program switching in drosophila. Cell Reports 2013; 3:160-72; PMID:23333275; http://dx.doi.org/10.1016/j.celrep.2012.12.014
   PubMed Web of Science ®Google Scholar
• Wu L-S, Cheng W-C, Hou S-C, Yan Y-T, Jiang S-T, Shen CKJ. TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis 2010; 48:56-62; PMID:20014337
   PubMed Web of Science ®Google Scholar
• Chiang P-M, Ling J, Jeong YH, Price DL, Aja SM, Wong PC. Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc Natl Acad Sci 2010; 107:16320-4.
   PubMed Web of Science ®Google Scholar
• Wu L-S, Cheng W-C, Shen CK. Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis (ALS)-like phenotypes in mice. J Biol Chem 2012; 287:27335-44.
   PubMed Web of Science ®Google Scholar
• Iguchi Y, Katsuno M, Niwa JI, Takagi S, Ishigaki S, Ikenaka K, Kawai K, Watanabe H, Yamanaka K, Takahashi R, et al. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain 2013; 136:1371-82; PMID:23449777
   PubMed Web of Science ®Google Scholar
• Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 2011; 14:459-68; PMID:21358643; http://dx.doi.org/10.1038/nn.2779
   PubMed Web of Science ®Google Scholar
• Harrison KA, Druey KM, Deguchi Y, Tuscano JM, Kehrl JH. A novel human homeobox gene distantly related to proboscipedia is expressed in lymphoid and pancreatic tissues. J Biol Chem 1994; 269:19968-75; PMID:7914194
   PubMed Web of Science ®Google Scholar
• Harrison KA, Thaler J, Pfaff SL, Gu H, Kehrl JH. Pancreas dorsal lobe agenesis and abnormal islets of Langerhans in Hlxb9-deficient mice. Nat Genet 1999; 23:71-5; PMID:10471502
   PubMed Web of Science ®Google Scholar
• Li H, Arber S, Jessell TM, Edlund H. Selective agenesis of the dorsal pancreas in mice lacking homeobox gene Hlxb9. Nat Genet 1999; 23:67-70; PMID:10471501
   PubMed Web of Science ®Google Scholar
• Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, Suh E, Van Deerlin VM, Wood EM, Baek Y, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 2013; 74:20-38; PMID:23686809; http://dx.doi.org/10.1002/ana.23937
   PubMed Web of Science ®Google Scholar
• Yang C, Wang H, Qiao T, Yang B, Aliaga L, Qiu L, Tan W, Salameh J, McKenna-Yasek DM, Smith T, et al. Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2014; 111:E1121-9; PMID:24616503; http://dx.doi.org/10.1073/pnas.1322641111
   PubMed Web of Science ®Google Scholar
• Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 2009; 187:761-72.; PMID:19951898; http://dx.doi.org/10.1083/jcb.200908164
   PubMed Web of Science ®Google Scholar
• Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 2007; 10:615-22; PMID:17435755; http://dx.doi.org/10.1038/nn1876
   PubMed Web of Science ®Google Scholar
• Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 2007; 10:608-14; PMID:17435754; http://dx.doi.org/10.1038/nn1885
   PubMed Web of Science ®Google Scholar
• Papadeas ST, Kraig SE, O'Banion C, Lepore AC, Maragakis NJ. Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo. Proc Natl Acad Sci U S A 2011; 108:17803-8; PMID:21969586; http://dx.doi.org/10.1073/pnas.1103141108
   PubMed Web of Science ®Google Scholar
• Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, Song S, Likhite S, Murtha MJ, Foust KD, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 2011; 29:824-8; PMID:21832997; http://dx.doi.org/10.1038/nbt.1957
   PubMed Web of Science ®Google Scholar
• Haidet-Phillips AM, Gross SK, Williams T, Tuteja A, Sherman A, Ko M, Jeong YH, Wong PC, Maragakis NJ. Altered astrocytic expression of TDP-43 does not influence motor neuron survival. Exp Neurol 2013; 250:250-9; PMID:24120466; http://dx.doi.org/10.1016/j.expneurol.2013.10.004
   PubMed Web of Science ®Google Scholar
• Tong J, Huang C, Bi F, Wu Q, Huang B, Liu X, Li F, Zhou H, Xia XG. Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. Embo J 2013; 32:1917-26; PMID:23714777; http://dx.doi.org/10.1038/emboj.2013.122
   PubMed Web of Science ®Google Scholar
• Rojas F, Cortes N, Abarzua S, Dyrda A, van Zundert B. Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress. Front Cell Neurosci 2014; 8:24; PMID:24570655; http://dx.doi.org/10.3389/fncel.2014.00024
   PubMed Web of Science ®Google Scholar
• Bi F, Huang C, Tong J, Qiu G, Huang B, Wu Q, Li F, Xu Z, Bowser R, Xia XG, et al. Reactive astrocytes secrete lcn2 to promote neuron death. Proc Natl Acad Sci U S A 2013; 110:4069-74; PMID:23431168; http://dx.doi.org/10.1073/pnas.1218497110
   PubMed Web of Science ®Google Scholar
• Shiga A, Ishihara T, Miyashita A, Kuwabara M, Kato T, Watanabe N, Yamahira A, Kondo C, Yokoseki A, Takahashi M, et al. Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS. PLoS One 2012; 7:e43120; PMID:22900096
   PubMed Web of Science ®Google Scholar